I am a Black British man with an African name living in the United States. There are many times when I feel that I alone represent a whole group of people. I felt the weight of that responsibility every day when I started my career in drug development because in most meetings, I was the only person of color.
52 physicians from across the U.S. selected for the inaugural cohort of the five-year, $100 million initiative
PRINCETON, N.J., October 22, 2021 /3BL Media/ - The Bristol Myers Squibb Foundation (BMSF), together with its partners, National Medical Fellowships (NMF) and the American Association for Cancer Research (AACR), today announced th
Saliendo! Our OLA and PRIDE Alliance PBRGs teamed up to host an empowering storytelling forum featuring BristolMyersSquibb employees reflecting on their coming out journeys within Hispanic & LatinX communities.
$1 million donation to Special Olympics supports mission of building a more inclusive world
Bristol Myers Squibb will donate $1 million to Special Olympics as part of the company’s global workforce charity event, BMS for Community. During the event, employees, their families and patients came together to move for minutes in any way that felt most comfortable, with the goal of supporting Special Olympics in its efforts to build a world celebrating people of all abilities.
Last year, our employee-led People & Business Resource Groups identified impactful organizations fighting disparities and discrimination. When U.S. and Puerto Rico-based employees donate to these selected groups, the Bristol Myers Squibb Foundation double-matches their gifts. Learn more about this special Employee Giving program.
More than 150 colleagues from 14 EU countries just finished cycling 3,000 km in our Country 2 Country 4 Cancer (C2C4C) event to raise awareness and much-needed donations for cancer research. It’s more than a bike ride — together, as one global BMS family, it’s part of our long-standing commitment to cancer research and our patients.
PRINCETON, N.J. and CAMBRIDGE, Mass., December 10, 2018 /3BL Media/ - Bristol-Myers Squibb Company (NYSE: BMY) and LabCentral, an innovative, shared laboratory space designed as a launchpad for life-sciences and biotech startups, today announced that ReviveMed and Strand Therapeutics are the winners of Bristol-Myers Squibb’s 2018 Golden Tickets for LabCentral.